Ibrahim, Nageatte

5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001.

Hamid, Omid , Hodi, F. Stephen , Hwu, Wen‐Jen , Dronca, Roxana , Mitchell, Tara C. , Patnaik, Amita , Zarour, Hassane M. , Jensen, Erin , Ibrahim, Nageatte , Ahsan, Sama, Robert, Caroline , Daud, Adil , Kefford, Richard , Wolchok, Jedd D. , Hersey, Peter , Joseph, Richard W. , Weber, Jeffrey S. , Joshua, Anthony M. , Ribas, Antoni

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9516-9516

10.1200/jco.2018.36.15_suppl.9516